Application of Central Composite Design Approach for Optimization of Gastric Floating Minitablets of Valsartan
International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) · 31.08.2026 · 19 (4) · 8833-8847
DOI: 10.37285/ijpsn.2026.19.4.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), online erschienen am 31.08.2026. Verfasst von Rajesh Pawar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Antihypertensive agents often exhibit a short half-life, limited gastric retention time, and low bioavailability, necessitating stable drug concentrations for effective hypertension management. Utilizing a gastroretentive system can enhance receptor selectivity and improve the pharmacological efficacy of these medications.
Aim
This research aims to formulate floating minitablets of Valsartan, designed for stomach-specific delivery with controlled release using HPMC K100MCR, Carbopol 974P, Aerosil R972, and Glyceryl dibehenate. This novel gastro-retentive formulation aims to enhance site-specific absorption and therapeutic efficacy in the upper gastrointestinal tract.
Method
Valsartan minitablets were prepared using wet granulation, involving the granulation and drying of excipients, followed by the addition of Carbomer and lubricant before compacting with a Rimek Minipress. A nonlinear quadratic polynomial model, developed with Design Expert software, analysed the effects of Carbopol 974P, HPMC K100MCR, Glyceryl dibehenate, and Aerosil R972 on key parameters such as floating lag time and dissolution. Factorial and central composite designs were used for systematic exploration, with statistical validation including ANOVA and relative error calculations, and results depicted through response surfaces and contour plots.
Result
The study optimized floating valsartan minitablets by correlating formulation components with critical quality attributes using factorial and central composite designs. The refined central composite model enhanced accuracy, and the final formulation, validated through in vitro tests, showed improved drug release compared to the marketed product. Stability studies confirmed its robustness over six months.
Conclusion
In conclusion, the optimized gastric floating mini-tablets of valsartan, developed through a combination of floating and mucoadhesion techniques, demonstrated effective gastroretention and sustained drug release, with promising pharmacokinetic properties in virtual in vivo studies, making them a viable solution for drugs having lower absorption windows in the upper GI tract.
Zitieren
APA
Pawar, R., Podutwar, A., Chabukswar, A., & Jagdale, S. (2026). Application of Central Composite Design Approach for Optimization of Gastric Floating Minitablets of Valsartan. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), 19(4), 8833-8847. https://doi.org/10.37285/ijpsn.2026.19.4.2
Vancouver
Pawar R, Podutwar A, Chabukswar A, Jagdale S. Application of Central Composite Design Approach for Optimization of Gastric Floating Minitablets of Valsartan. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 2026;19(4):8833-8847. doi:10.37285/ijpsn.2026.19.4.2
BibTeX
@article{Pawar2026,
author = {Pawar, Rajesh and Podutwar, Akash and Chabukswar, Anuruddha and Jagdale, Swati},
title = {Application of Central Composite Design Approach for Optimization of Gastric Floating Minitablets of Valsartan},
journal = {International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)},
year = {2026},
volume = {19},
number = {4},
pages = {8833--8847},
doi = {10.37285/ijpsn.2026.19.4.2}
}
EUVIMED